John Wiley & Sons Sees FY25 Adj. EPS $3.25-$3.60; Revenue $1.65B-$1.69B Vs $1.67B Est.
John Wiley & Sons Sees FY25 Adj. EPS $3.25-$3.60; Revenue $1.65B-$1.69B Vs $1.67B Est.
FISCAL YEAR 2025 GROWTH OUTLOOK
2025财年增长展望
Wiley is reaffirming its Fiscal 2025 growth outlook based on first half results and second half indicators. Wiley's revenue outlook is driven by favorable demand trends and performance indicators. Wiley's earnings outlook is driven by expected revenue growth and cost savings, while reflecting reinvestments to scale and optimize Research, modernize infrastructure and expand GenAI content licensing and capabilities. Wiley's cash flow outlook is driven by lower restructuring payments and favorable working capital partially offset by a year-over-year swing in incentive compensation payments.
Wiley根据上半年的业绩和下半年的因子重申其2025财年的增长展望。Wiley的营业收入展望受到有利的需求趋势和业绩因子的驱动。Wiley的盈利展望受到预期的营业收入增长和节约成本的驱动,同时反映出在扩大和优化研究、现代化制造行业以及扩展GenAI内容许可和能力方面的再投资。Wiley的现金流展望受到较低的重组支付和有利的营运资金的驱动,部分被年度激励补偿支付的转变所抵消。
Quarterly phasing in the second half of the year: The Company's projected growth in the second half of its fiscal year is expected to occur in Q4 due to strong momentum and favorable comparisons in Research.
下半年的季度安排:公司预计在财年下半年的增长将发生在第四季度,因研究领域的强劲势头和有利对比。
Metric ($millions, except EPS) |
Fiscal 2024 Results Ex-Divestitures |
Fiscal 2025 Outlook Ex-Divestitures |
Adj. Revenue* | $1,617 | $1,650 to $1,690 |
Research | $1,043 | Low to mid-single digit growth |
Learning | $574 | Low-single digit growth |
Adj. EBITDA* | $369 | $385 to $410 |
Adj. EPS* | $2.78 | $3.25 to $3.60 |
Free Cash Flow | $114 | Approx. $125 |
*Excludes held for sale or sold businesses |
Metric (百万美元,除每股收益外) |
2024财政年度成果 除出售资产外 |
2025财年展望 除出售资产外 |
调整后的营业收入* | $1,617 | $1,650到$1,690 |
研究 | $1,043 | 低到中个位数的增长 |
学习 | $574 | 低个位数增长 |
调整后EBITDA* | $369 | $385到$410 |
调整后每股收益* | $2.78 | $3.25到$3.60 |
自由现金流 | $114 | 约125美元 |
*不包括待售或已售业务 |
The Company remains on track with its Fiscal 2026 targets.
公司仍按计划推进2026财年的目标。